The Right Drug for the Right Resident: 5 Practical Strategies for Long-Term Care Pharmacies to Improve Outcomes

Why It Matters

Implementing these evidence‑based workflows enhances resident safety, lowers total cost of care, and positions LTC pharmacies as strategic partners rather than cost‑cutters.

Key Takeaways

• Structured MRR/MMR triggers actionable, repeatable recommendations
• Beta‑3 agonists replace anticholinergics, lowering fall risk
• Formulation checks prevent aspiration and dosing errors
• Pharmacy‑run vaccine clinics boost coverage and revenue
• Indication‑first antipsychotic selection drives safer deprescribing

Pulse Analysis

Long‑term care pharmacies sit at the nexus of complex medication regimens and evolving Medicare Part D policies. By embedding structured medication regimen reviews into daily operations, pharmacists can systematically flag high‑risk agents, assess functional tolerability, and surface preventive opportunities such as vaccinations. This disciplined approach transforms a compliance checkbox into a "change engine" that drives consistent, evidence‑based prescribing across facilities.

Therapeutic substitution is another lever for age‑friendly care. Shifting default therapy for overactive bladder from anticholinergics to beta‑3 agonists mitigates cognitive decline and fall risk, while rigorous formulation reviews for dysphagia prevent aspiration and dosing errors. These clinical choices not only improve resident outcomes but also reduce downstream utilization, aligning financial incentives with quality metrics under Medicare.

Pharmacy‑led vaccine initiatives and antipsychotic stewardship further illustrate how clinical expertise can be monetized responsibly. Seasonal immunization clinics, integrated with admission assessments and consultant‑pharmacist visits, close coverage gaps and generate billable revenue. Simultaneously, indication‑first antipsychotic selection paired with meticulous documentation supports Part D protected‑class requirements and facilitates safe deprescribing. Together, these strategies position LTC pharmacies as essential, revenue‑positive partners in delivering high‑value, resident‑centered care.